Stock listing
Frankfurt:ZRE DocMorris Ltd Aktie
German listing (Frankfurt) of DocMorris Ltd · home listing SIX Swiss:DOCM
Follow DocMorris Ltd into a list and get an email when it puts out news.
Share price · FWB:ZRE
€19.43 EUR -0.27 (-1.4%)
Close on Nov 20, 2026
- Day range
- €19.43 – €19.43 EURNov 20, 2026
- Market cap
- €990.6M EURAt the close on Nov 20, 2026 · price × 50.98M shares outstanding
- 52-week range
- €4.29 – €21.00 EURLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- €43,574 EURMedian day 303 shares · 14 days with no trades · last 3 months, Aug 20, 2026 – Nov 13, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| SIX Swiss:DOCM · Home | 18.53 CHF | +0.53 (+2.9%) | 785,464 | 18.47 | 19.02 | 18.30 | 18.00 | Close on Nov 20, 2026 |
| LSE:0RRB | 18.63 CHF | -0.17 (-0.9%) | 83,710 | 18.46 | 19.00 | 18.31 | 18.80 | Close on Nov 20, 2026 |
| Frankfurt:ZRE | €19.43 EUR | -0.27 (-1.4%) | — | €19.43 | €19.43 | €19.43 | €19.70 | Close on Nov 20, 2026 |
Daily closes
Last 3 months, Aug 20, 2026 – Nov 13, 2026 · FWB:ZRE · EUR, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| €20.79 | +0.50 | +2.5% | €20.38 | €21.00 | €20.33 | 30 | |
| €20.29 | +0.156 | +0.8% | €20.93 | €20.96 | €20.24 | 650 | |
| €20.14 | +0.141 | +0.7% | €19.88 | €20.18 | €19.86 | 18,570 | |
| €19.99 | +1.028 | +5.4% | €18.56 | €20.58 | €18.55 | 810 | |
| €18.97 | +0.592 | +3.2% | €17.94 | €19.03 | €17.90 | 480 | |
| €18.37 | -0.163 | -0.9% | €18.02 | €18.56 | €17.77 | 26 | |
| €18.54 | +1.502 | +8.8% | €17.51 | €18.76 | €17.40 | 13,896 | |
| €17.04 | -0.699 | -3.9% | €17.04 | €17.04 | €17.04 | 13,896 | |
| €17.73 | +0.446 | +2.6% | €17.73 | €17.73 | €17.73 | 413 | |
| €17.29 | +0.805 | +4.9% | €17.26 | €17.31 | €17.25 | 305 | |
| €16.48 | -0.525 | -3.1% | €16.98 | €16.99 | €16.48 | 305 | |
| €17.01 | +0.04 | +0.2% | €17.01 | €17.01 | €17.01 | 48 | |
| €16.97 | +0.927 | +5.8% | €17.07 | €17.07 | €16.83 | 276 | |
| €16.04 | -0.977 | -5.7% | €15.95 | €16.06 | €15.89 | 259 | |
| €17.02 | +0.259 | +1.5% | €17.02 | €17.02 | €17.02 | 2,898 | |
| €16.76 | -0.301 | -1.8% | €16.76 | €16.76 | €16.76 | 60 | |
| €17.06 | +0.356 | +2.1% | €17.06 | €17.06 | €17.06 | 0 | |
| €16.70 | -0.21 | -1.2% | €16.70 | €16.70 | €16.70 | 0 | |
| €16.91 | +0.333 | +2.0% | €17.03 | €17.04 | €16.88 | 100 | |
| €16.58 | -0.462 | -2.7% | €16.58 | €16.58 | €16.58 | 0 | |
| €17.04 | +0.385 | +2.3% | €15.51 | €17.08 | €15.43 | 0 | |
| €16.66 | +1.802 | +12.1% | €15.67 | €16.90 | €15.64 | 1,970 | |
| €14.86 | +0.565 | +4.0% | €14.86 | €14.86 | €14.86 | 0 | |
| €14.29 | +0.085 | +0.6% | €14.29 | €14.29 | €14.29 | 0 | |
| €14.21 | -0.817 | -5.4% | €14.09 | €14.23 | €14.09 | 1,400 | |
| €15.02 | +0.577 | +4.0% | €14.98 | €15.08 | €14.85 | 240 | |
| €14.45 | +1.023 | +7.6% | €14.39 | €14.49 | €14.21 | 26,250 | |
| €13.42 | +0.048 | +0.4% | €13.42 | €13.42 | €13.42 | 0 | |
| €13.38 | +0.40 | +3.1% | €13.37 | €13.38 | €13.17 | 145 | |
| €12.98 | -0.388 | -2.9% | €13.52 | €13.72 | €12.98 | 580 | |
| €13.36 | -0.171 | -1.3% | €13.36 | €13.36 | €13.36 | 16,682 | |
| €13.53 | +0.169 | +1.3% | €13.53 | €13.53 | €13.53 | 0 | |
| €13.37 | +0.31 | +2.4% | €13.37 | €13.37 | €13.37 | 300 | |
| €13.06 | +0.522 | +4.2% | €12.84 | €13.22 | €12.65 | 250 | |
| €12.53 | +1.305 | +11.6% | €12.11 | €12.61 | €12.08 | 1,150 | |
| €11.23 | -0.226 | -2.0% | €11.23 | €11.23 | €11.23 | 9,114 | |
| €11.45 | -0.782 | -6.4% | €11.45 | €11.45 | €11.45 | 0 | |
| €12.24 | +0.301 | +2.5% | €12.24 | €12.24 | €12.24 | 0 | |
| €11.94 | +0.387 | +3.4% | €11.68 | €12.05 | €11.65 | 2,500 | |
| €11.55 | +0.609 | +5.6% | €11.22 | €11.58 | €11.21 | 1,040 | |
| €10.94 | +0.109 | +1.0% | €10.94 | €10.94 | €10.94 | 8,440 | |
| €10.83 | +0.355 | +3.4% | €10.83 | €10.83 | €10.83 | 0 | |
| €10.48 | -0.018 | -0.2% | €10.48 | €10.48 | €10.48 | 0 | |
| €10.49 | +0.216 | +2.1% | €10.26 | €10.67 | €10.25 | 300 | |
| €10.28 | -0.59 | -5.4% | €10.39 | €10.58 | €10.18 | 610 | |
| €10.87 | -0.668 | -5.8% | €10.87 | €10.87 | €10.87 | 8,776 | |
| €11.54 | -0.10 | -0.9% | €11.54 | €11.54 | €11.54 | 300 | |
| €11.64 | +0.953 | +8.9% | €10.57 | €11.66 | €10.53 | 30,900 | |
| €10.68 | -0.686 | -6.0% | €11.26 | €11.29 | €10.59 | 50 | |
| €11.37 | +0.088 | +0.8% | €11.35 | €11.38 | €11.33 | 2,005 | |
| €11.28 | +0.309 | +2.8% | €10.86 | €11.31 | €10.69 | 11,126 | |
| €10.97 | -0.244 | -2.2% | €10.88 | €11.02 | €10.77 | 500 | |
| €11.22 | -0.305 | -2.6% | €11.22 | €11.22 | €11.22 | 0 | |
| €11.52 | -0.107 | -0.9% | €11.52 | €11.52 | €11.52 | 0 | |
| €11.63 | +0.311 | +2.7% | €11.65 | €11.73 | €11.60 | 100 | |
| €11.32 | -0.18 | -1.6% | €11.32 | €11.32 | €11.32 | 5,996 | |
| €11.50 | +0.767 | +7.1% | €10.88 | €11.54 | €10.73 | 120 | |
| €10.73 | -0.043 | -0.4% | €10.67 | €10.73 | €10.49 | 836 | |
| €10.77 | +0.05 | +0.5% | €10.49 | €10.99 | €10.49 | 450 | |
| €10.72 | -0.246 | -2.2% | €10.61 | €10.73 | €10.58 | 100 | |
| €10.97 | -0.245 | -2.2% | €10.97 | €10.97 | €10.97 | 6,344 | |
| €11.21 | +0.572 | +5.4% | €10.90 | €11.25 | €10.88 | 1,020 |
- Ticker
- Frankfurt:ZRE
- Asset type
- Stock
- Sector
- Retail & consumer services
- Industry
- Retail & e-commerce
- Exchange
- Frankfurt
- Currency
- EUR
What changed lately
Latest news release · Jun 25, 2026
Online pharmacy DocMorris launches AI-driven cost-savings programme, cuts 100 jobs
Latest earnings call · Aug 19, 2026
DocMorris (SIX Swiss: DOCM) Q2 2026 Earnings Call
Replay and transcript
Latest deck · Aug 19, 2026
H1 2026 Earnings Presentation
Earnings · 31 slides
Latest news
Online pharmacy DocMorris launches AI-driven cost-savings programme, cuts 100 jobs
Jun 25, 2026
Closed €8.90 (+5.2%) on Jun 25, 2026
Stiftung Warentest tests online pharmacies: DocMorris comes out on top
May 27, 2026
Closed €7.28 (+0.1%) on May 27, 2026
2026 Annual General Meeting: Strong vote by shareholders in favour of continuity in leadership and strategy
May 12, 2026
Closed €7.80 (+1.9%) on May 13, 2026
Shareholder CEPD Says It Rejects DocMorris' Mischaracterisation And Emphasizes Case For Real Governance Reform
Apr 16, 2026
Closed €6.98 (+1.3%) on Apr 17, 2026
DocMorris enhances its leading AI-powered health platform by partnering with Hello Inside to address metabolic healthcare
Apr 14, 2026
Closed €6.00 (+2.7%) on Apr 14, 2026
CEPD N.V Proposes To AGM Of DocMorris Major Renewal Of Board Of Directors
Mar 25, 2026
Closed €4.29 (-0.6%) on Mar 25, 2026
DOCM: Strong Rx and digital growth, margin expansion, and Google partnership set up 2026 EBITDA breakeven
Mar 19, 2026
Closed €4.57 (-2.4%) on Mar 19, 2026
DocMorris AG announces changes to its Board of Directors
Mar 3, 2026
Closed €5.63 (+2.4%) on Mar 3, 2026
DocMorris receives TÜV certification for temperature-controlled delivery of pharmaceuticals
Feb 20, 2026
Closed €5.85 (-2.5%) on Feb 20, 2026
DocMorris and Infermedica simplify health: from symptoms to solutions with the AI health companion
Feb 12, 2026
Closed €6.24 (-2.7%) on Feb 12, 2026
DocMorris Ltd on 6ix
- Industry
- Retail & e-commerce
- News releases
- 15 in the last 12 months · 29 in all · newest Jun 25, 2026 · oldest 2024
- Calls
- 15 calls with a replay · 15 with a transcript · latest Aug 19, 2026
- Decks
- 13 decks · latest Aug 19, 2026
Where DocMorris Ltd is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| SIX Swiss:DOCM · Home listing | SIX Swiss | Switzerland | CHF |
| gettex:ZRE | gettex | Germany | EUR |
| BX Swiss:DOCM | BX Swiss | Switzerland | CHF |
| LSE:0RRB | LSE | United Kingdom | CHF |
| Tradegate:ZRE | Tradegate | Germany | EUR |
| Aquis:DOCMZ | Aquis | United Kingdom | CHF |
| Lang & Schwarz:A0Q6J0 | Lang & Schwarz | Germany | EUR |
| LS Exchange:A0Q6J0 | LS Exchange | Germany | EUR |
| OTC:ZRSEF | OTC | United States | USD |
| Frankfurt:ZRE · This page | Frankfurt | Germany | EUR |
| Munich:ZRE | Munich | Germany | EUR |
| Stuttgart:ZRE | Stuttgart | Germany | EUR |
| Dusseldorf:ZRE | Dusseldorf | Germany | EUR |
| Hamburg:ZRE | Hamburg | Germany | EUR |
| Turquoise:DOCMZ | Turquoise | United Kingdom | CHF |
| Hanover:ZRE | Hanover | Germany | EUR |
| Xetra:ZRE | Xetra | Germany | EUR |
Valuation
EV/sales 1.0× against a median of 0.8×: 7th lowest of 11 Retail & e-commerce companies shown. Statements: Year to Dec 31, 2025 · balance Jun 30, 2026 · price Nov 20, 2026
- Enterprise value
- 1.12B CHF
- P/E
- Loss
- EV/sales
- 1.0×
- EV/EBITDA
- Negative EBITDA
- Price/book
- 2.6×
- Gross margin
- 9.4%
- Operating margin
- −7.5%
- Net margin
- −11.9%
- Debt to equity
- 0.7×
- Beta
- No index for this market yet
Retail & e-commerce: the 10 companies nearest in size, of 506 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| DocMorris Ltd · SIX:DOCM | US$1.13B | US$1.33B | n/a | 1.0× | n/a | 2.6× | −11.9% | 0.7× | n/a |
| Fox-Wizel Ltd. · TASE:FOX | US$1.19B | US$2.61B | 17.1× | 1.2× | 5.7× | 2.2× | 3.2% | 3.8× | n/a |
| MarineMax, Inc. (fl) · NYSE:HZO | US$1.19B | US$2.00B | n/a | 0.9× | 19.7× | 1.3× | −0.4% | 1.0× | 1.04 |
| Rusta AB · OMXSTO:RUSTA | US$1.17B | US$1.64B | 20.2× | 1.3× | 8.3× | 5.0× | 4.6% | 2.3× | n/a |
| Sonic Automotive, Inc. · NYSE:SAH | US$1.15B | US$2.89B | 5.6× | 0.2× | 4.4× | 1.1× | 1.3% | 1.6× | 0.70 |
| BlueStone Jewellery and Lifestyle Limited · NSE:BLUESTONE | US$1.14B | US$1.34B | 98.9× | 4.3× | 25.0× | 5.7× | 3.6% | 1.3× | n/a |
| Siam Global House Public Co., Ltd. · SET:GLOBAL | US$1.13B | US$1.11B | 14.0× | 1.2× | 9.7× | 1.4× | 8.7% | 0.0× | n/a |
| Grocery Outlet Holding Corp. · NASDAQ:GO | US$1.13B | US$1.57B | n/a | 0.3× | n/a | 1.4× | −8.0% | 0.6× | 0.68 |
| Fnac Darty SA · EURONEXT:FNAC | US$1.13B | US$3.56B | n/a | 0.3× | 4.6× | 0.8× | −1.4% | 2.1× | n/a |
| Magazine Luiza S.A. · BMFBOVESPA:MGLU3 | US$1.07B | US$2.21B | n/a | 0.3× | 6.0× | 0.6× | −0.0% | 0.8× | n/a |
| Dis-Chem Pharmacies Limited · JSE:DCP | US$1.06B | US$1.41B | 19.0× | 0.6× | 7.6× | 3.1× | 2.3% | 1.1× | n/a |
| Median of the others | US$1.13B | US$1.82B | 18.1× | 0.8× | 7.6× | 1.4× | 1.8% | 1.2× | 0.70 |
Forecasts
Analysts' consensus from EODHD, read Nov 20, 2026. Not 6ix's view and not investment advice.
- Price target
- 16.22 CHF · Analysts' mean
- EPS, year to Dec 2026
- -1.63 · 6 analysts
- Revenue, year to Dec 2026
- 1.28B · 6 analysts
Team and board
| Officer | Role |
|---|---|
| Walter Hess | CEO |
| Daniel Grigat | Head of Investor Relations & Sustainability |
| Kelvin Jörn | Head of Investor Relations |
| Moritz Stahlhut | Investor Relations Manager |
Events
- Next results
- Mar 18, 2027 (expected)
Calls
| Call | When | Status |
|---|---|---|
| DocMorris (SIX Swiss: DOCM) Q2 2026 Earnings Call | Tue, Aug 18, 2026 · 8:00 PM ET | Replay |
| DocMorris (SIX Swiss: DOCM) Q1 2026 Earnings Call | Thu, Apr 16, 2026 · 5:00 AM ET | Replay |
| DocMorris (SIX Swiss: DOCM) Q4 2025 Earnings Call | Wed, Mar 18, 2026 · 8:00 PM ET | Replay |
| DocMorris (SIX Swiss: DOCM) Q2 2025 Earnings Call | Tue, Aug 19, 2025 · 5:00 AM ET | Replay |
| DocMorris (SIX Swiss: DOCM) Q4 2024 Earnings Call | Thu, Mar 13, 2025 · 5:00 AM ET | Replay |
| DocMorris (SIX Swiss: DOCM) Q2 2024 Earnings Call | Tue, Aug 20, 2024 · 5:00 AM ET | Replay |
| DocMorris (SIX Swiss: DOCM) Q4 2023 Earnings Call | Thu, Mar 21, 2024 · 5:00 AM ET | Replay |
| DocMorris (SIX Swiss: DOCM) Q2 2023 Earnings Call | Thu, Aug 17, 2023 · 5:00 AM ET | Replay |
| DocMorris (SIX Swiss: DOCM) Q4 2022 Earnings Call | Thu, Mar 23, 2023 · 5:00 AM ET | Replay |
| DocMorris (SIX Swiss: DOCM) Q2 2022 Earnings Call | Thu, Aug 18, 2022 · 5:00 AM ET | Replay |
All 15 calls
| Call | When | Status |
|---|---|---|
| DocMorris (SIX Swiss: DOCM) Q4 2021 Earnings Call | Thu, Mar 24, 2022 | Replay |
| DocMorris (SIX Swiss: DOCM) Q2 2021 Earnings Call | Wed, Aug 18, 2021 | Replay |
| DocMorris (SIX Swiss: DOCM) Q4 2020 Earnings Call | Thu, Mar 18, 2021 | Replay |
| DocMorris (SIX Swiss: DOCM) Q2 2020 Earnings Call | Wed, Aug 19, 2020 | Replay |
| DocMorris (SIX Swiss: DOCM) Q4 2019 Earnings Call | Thu, Mar 19, 2020 | Replay |
Results days
| Quarter | Results | Share move |
|---|---|---|
| Q2 2026 | Jun 30, 2026 | +3.9% |
| Quarter to Mar 31, 2026 | Apr 16, 2026 | +15.2% |
| Q4 2025 | Dec 31, 2025 | +0.7% |
| Quarter to Sep 30, 2025 | Oct 16, 2025 | +1.1% |
| Q2 2025 | Aug 19, 2025 · After close | +2.2% |
| Q1 2025 | May 8, 2025 · Before open | −8.0% |
| Q4 2024 | Mar 13, 2025 | −21.4% |
| Quarter to Sep 30, 2024 | Oct 15, 2024 | +2.7% |
| Q2 2024 | Aug 20, 2024 | −12.1% |
| Q1 2024 | May 23, 2024 · After close | +3.4% |
All 20 quarters
| Quarter | Results | Share move |
|---|---|---|
| Q4 2023 | Mar 21, 2024 | +6.4% |
| Q3 2023 | Oct 19, 2023 | −22.0% |
| Q2 2023 | Aug 17, 2023 · Before open | +7.8% |
| Q1 2023 | Apr 20, 2023 · After close | +1.6% |
| Q4 2022 | Mar 23, 2023 · After close | −5.8% |
| Q3 2022 | Oct 20, 2022 · Before open | +1.4% |
| Q2 2022 | Aug 18, 2022 · Before open | +8.4% |
| Q1 2022 | Apr 20, 2022 | −2.6% |
| Q4 2021 | Mar 24, 2022 · Before open | −12.7% |
| Q3 2021 | Oct 21, 2021 · Before open | −7.7% |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| H1 2026 Earnings Presentation | Earnings | 31 slides | Aug 19, 2026 |
| Q1 2026 Earnings Presentation | Earnings | 13 slides | Apr 16, 2026 |
| H1 2025 Earnings Presentation | Earnings | 30 slides | Aug 19, 2025 |
| FY2024 Earnings Presentation | Earnings | 31 slides | Mar 13, 2025 |
| H1 2024 Earnings Presentation | Earnings | 35 slides | Aug 20, 2024 |
| FY2023 Earnings Presentation | Earnings | 36 slides | Mar 21, 2024 |
| H1 2023 Earnings Presentation | Earnings | 34 slides | Aug 17, 2023 |
| FY 2022 Earnings Presentation | Earnings | 34 slides | Mar 23, 2023 |
| H1 2022 Earnings Presentation | Earnings | 27 slides | Aug 18, 2022 |
| FY2021 Earnings Presentation | Earnings | 30 slides | Mar 24, 2022 |
All 13 decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| H1 2021 Earnings Presentation | Earnings | 21 slides | Aug 18, 2021 |
| FY2020 Earnings Presentation | Earnings | 40 slides | Mar 18, 2021 |
| H1 2020 Earnings Presentation | Earnings | 39 slides | Aug 19, 2020 |
Financings
| Raise | Date | In US dollars |
|---|---|---|
| 2028 convertible bonds Announced: CHF 49.6M | Oct 22, 2025 | US$62.31M |
| Capital raise Update: CHF 200M Use of proceeds: To fund growth | Apr 10, 2025 | US$240.7M |
Open Financings · Read by 6ix AI from the company's releases
Financials
Annual, in CHF
Income statement
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.12B | 1.02B | 969.5M | 931.0M | 1.73B | 1.48B | 1.36B | 1.21B | 982.9M | 879.5M |
| Cost of revenue | 1.02B | 800.5M | 766.1M | 1.36B | 1.47B | 1.24B | 1.15B | 1.02B | 836.3M | 747.6M |
| Gross profit | 105.7M | 216.5M | 203.3M | 160.2M | 260.0M | 241.3M | 208.7M | 191.2M | 146.6M | 131.9M |
| Selling, general and administrative | 221.9M | 24.0M | 25.5M | 59.2M | 52.9M | 50.9M | 34.9M | 24.9M | 27.4M | 21.5M |
| Operating income | -84.3M | -104.2M | -75.8M | 40.5M | -197.5M | -117.6M | -45.7M | -31.4M | -21.2M | -7.09M |
| Depreciation and amortization | 44.9M | 45.6M | 43.4M | 39.6M | 51.1M | 39.3M | 31.9M | 18.9M | 11.5M | 9.21M |
| EBITDA | -39.4M | -58.6M | -32.4M | 80.1M | -146.4M | -78.4M | -13.8M | -12.5M | -9.69M | 2.12M |
| Interest expense | 17.7M | 20.0M | 19.1M | 18.6M | 17.4M | 15.7M | 5.90M | 2.12M | 2.30M | 3.03M |
| Income before tax | -122.0M | -102.8M | -118.7M | -169.9M | -226.7M | -133.2M | -50.1M | -38.5M | -36.5M | -12.7M |
| Income tax | 12.4M | -5.50M | -1.09M | 2.00M | -949.0K | 2.44M | 2.27M | 553.0K | -241.0K | 53.0K |
| Net income | -134.4M | -97.3M | 82.3M | -171.1M | -225.7M | -135.7M | -52.4M | -39.0M | -36.2M | -12.8M |
| Earnings per share, basic | -2.60 | -4.06 | 3.47 | -7.82 | -23.40 | -14.95 | -2.98 | -3.02 | -3.24 | -0.92 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 119.9M | 95.4M | 54.0M | 126.0M | 277.7M | 300.6M | 204.7M | 230.7M | 107.8M | 25.2M |
| Short-term investments | 30.0M | 0 | 50.0M | 30.0M | 460.0K | 358.0K | 225.0K | 153.0K | 174.0K | 160.0K |
| Receivables | 82.3M | 69.8M | 55.4M | 138.4M | 141.4M | 129.6M | 128.4M | 99.7M | 91.4M | 72.5M |
| Inventory | 48.6M | 37.1M | 51.8M | 83.2M | 92.5M | 92.6M | 70.6M | 69.4M | 58.6M | 48.3M |
| Current assets | 294.8M | 213.6M | 293.7M | 395.9M | 537.1M | 539.3M | 428.1M | 416.7M | 272.3M | 159.6M |
| Property, plant and equipment | 42.3M | 50.6M | 62.1M | 96.8M | 98.7M | 96.6M | 77.1M | 34.3M | 29.7M | 26.2M |
| Goodwill | 361.1M | 364.8M | 360.4M | 400.8M | 418.4M | 435.3M | 334.7M | 172.4M | 79.3M | 10.4M |
| Total assets | 825.4M | 778.1M | 866.4M | 1.10B | 1.27B | 1.28B | 991.7M | 726.5M | 456.8M | 261.5M |
| Accounts payable | 60.0M | 59.4M | 38.5M | 112.8M | 132.2M | 93.3M | 92.1M | 83.1M | 75.3M | 70.7M |
| Current liabilities | 134.5M | 116.5M | 180.3M | 241.3M | 212.5M | 156.7M | 212.6M | 119.0M | 114.3M | 138.2M |
| Long-term debt | 248.1M | 285.8M | 211.4M | 460.2M | 485.4M | 483.9M | 313.8M | 142.8M | 29.2M | 5.00M |
| Total debt | 288.6M | 312.2M | 330.8M | 528.6M | 557.9M | 570.2M | 363.0M | 117.2M | 4.14M | 59.1M |
| Total liabilities | 416.3M | 438.0M | 435.9M | 748.7M | 784.3M | 746.7M | 586.2M | 282.9M | 162.5M | 157.7M |
| Shareholders' equity | 409.1M | 340.1M | 430.5M | 350.8M | 484.9M | 531.7M | 405.7M | 443.6M | 294.0M | 103.8M |
| Shares outstanding | 51.6M | 23.9M | 23.7M | 21.9M | 9.65M | 9.08M | 17.6M | 12.9M | 11.2M | 13.9M |
Cash flow
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | -88.3M | -26.6M | -87.4M | -97.3M | -130.6M | -67.5M | -82.6M | -33.2M | -22.2M | -13.8M |
| Capital spending | -1.77M | -28.6M | -27.7M | -59.3M | -63.5M | -59.8M | -41.5M | -31.5M | -21.6M | -19.9M |
| Free cash flow | -90.0M | -55.2M | -115.1M | -156.6M | -194.1M | -127.3M | -124.1M | -64.7M | -43.9M | -33.8M |
| Cash from investing | -52.5M | 93.9M | 219.8M | -89.8M | -67.3M | -199.9M | -143.2M | -140.3M | -62.2M | -23.1M |
| Cash from financing | 165.8M | -26.0M | -202.6M | 39.1M | 179.7M | 363.2M | 200.2M | 297.1M | 165.9M | 37.0M |
| Dividends paid | -7.58M | -157.9M | -204.9M | -56.1M | -1.64M | |||||
| Share buybacks | 212.4M | 73.0K | 31.0K | 42.1M | -4.00K | -2.00K | -1.00K | -6.37M | -383.0K | -243.0K |
| Change in cash | 24.5M | 41.3M | -72.0M | -151.7M | -22.9M | 95.9M | -26.0M | 122.9M | 82.5M | 136.0K |
Cap table
Built by 6ix from DocMorris Ltd’s releases · as of Oct 22, 2025
- Common shares
- 50,981,419
- Fully diluted
- 50,981,419
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 50,981,419 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 50,981,419 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Daniel Grigat | Head of Investor Relations & Sustainability · Since at least Nov 13, 2025 |
| Kelvin Jörn | Head of Investor Relations · Since at least May 12, 2026 |
| Moritz Stahlhut | Investor Relations Manager · Since at least Mar 3, 2026 |
| Walter Hess | CEO · Since at least Jul 17, 2025 |
Log in to ask 6ix AI your own questions about DocMorris Ltd.